Picture of Camurus AB logo

CAMX Camurus AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Momentum

Relative Strength (%)
1m+11.06%
3m-8.43%
6m+46.93%
1yr+107.88%
Volume Change (%)
10d/3m-16.87%
Price vs... (%)
52w High-14.85%
50d MA+1.66%
200d MA+29.92%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)62.17
PEG Ratio (f)4.52
EPS Growth (f)15.96%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value19.02
Price to Tang. Book19.31
Price to Free Cashflow47.51
Price to Sales16.54
EV to EBITDA50.44

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital34.17%
Return on Equity34.69%
Operating Margin30.63%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueSEKm105.61336600.57956.341,716.851,867.892,891.03103.39%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/a+753.47-24.78+200.02n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Camurus AB EPS forecast chart

Profile Summary

Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
October 8th, 2004
Public Since
December 3rd, 2015
No. of Employees
204
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
55,623,618
Blurred out image of a map
Address
Ideongatan 1A, LUND, 223 62
Web
https://www.camurus.com/
Phone
+46 462865730
Contact
Fredrik Joabsson
Auditors
PricewaterhouseCoopers AB

CAMX Share Price Performance

Upcoming Events for CAMX

Q1 2024 Camurus AB Earnings Release

Camurus AB Annual Shareholders Meeting

Camurus AB Annual Shareholders Meeting

Camurus AB at SEB Small & Midcap Seminar

Camurus AB at Handelsbanken Nordic Small & Mid Cap Seminar

Q2 2024 Camurus AB Earnings Release

Camurus AB at Nordea Small & Mid Cap Days

Similar to CAMX

Picture of Biogaia AB logo

Biogaia AB

se flag iconOMX Nordic Exchange Stockholm

Picture of BoneSupport Holding AB logo

BoneSupport Holding AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Calliditas Therapeutics AB logo

Calliditas Therapeutics AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Cline Scientific AB logo

Cline Scientific AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Corline Biomedical AB logo

Corline Biomedical AB

se flag iconOMX Nordic Exchange Stockholm

FAQ